Cinacalcet IMpurity
|
西那卡塞杂质
|
1229224-93-4
|
Montelukast iMpurity
|
孟鲁司特杂质
|
|
1-cyclopropyl-6-fluoro-1,4-dihydro-7-((4aR,7aS)-octahydropyrrolo [3,4-b]pyridin-6-yl)-8-Methoxy-4-oxoquinoline-3-carboxylic acid
|
莫西沙星杂质
|
1394029-14-1
|
N,N'-Desethylene-N,N'-diforMyl Levofloxacin
|
左氧氟沙星杂质
|
151377-74-1
|
Rivaroxaban iMpurity
|
利伐沙班杂质
|
1616563-62-2
|
1-(2,6-DICHLOROPHENYL)INDOLIN-2,3-DIONE
|
双氯芬酸钠杂质
|
|
Dapoxetine iMpurity
|
达泊西汀杂质
|
94305-25-6
|
Istradefylline iMpurity
|
伊曲茶碱杂质
|
|
Entecavir Impurity
|
恩替卡韦杂质
|
1333204-94-6
|
Terbinafine
|
特比萘芬杂质
|
151222-50-3
|
AlviMopan iMpurity
|
爱维莫潘杂质
|
|
Norfloxacin Imp.(EP)
|
诺氟沙星杂质
|
1911573-08-4
|
Cetirizine IMpurity (4-Chlorobenzophenone)
|
西替利嗪杂质
|
2724877-99-8
|
ethyl 4-hydroxy-2-oxopyrrolidine-1-acetate
|
奥拉西坦杂质
|
62613-81-4
|
(S)-N-(1-AMino-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide
|
硼替佐米杂质
|
289472-80-6
|
IMp. A (EP): (RS)-9,10-Difluoro-3-Methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid (FPA)
|
氧氟沙星杂质
|
|
SalMeterol iMpurity
|
沙美特罗杂质
|
144391-74-2
|
Clopidogrel
|
氯吡格雷杂质
|
1319197-71-1
|
Ezetimibe Impurity
|
依折麦布杂质
|
1510820-22-0
|
Diquafosol Impurity 1
|
地夸磷索杂质
|
26184-65-6
|
Benidipine Impurity
|
贝尼地平杂质
|
52604-00-9
|
Bisoprolol
|
比索洛尔
|
66722-44-9
|
Cabozantinib Impurity
|
卡博替尼杂质
|
1355031-15-0
|
nifedipine iMpurity
|
硝苯地平杂质
|
|
4-PYRIDIN-4-YL-BUTYRIC ACID
|
替罗非班杂质
|
102878-73-9
|
Amlodipine EP Impurity D
|
氨氯地平杂质A
|
113994-41-5
|
Fluconazole IMpurity [1, 3-Bis(1H-1, 2, 4-Triazole-1-yl)propan-2-one]
|
氟康唑杂质
|
1449785-88-9
|
Pabuximab impurity
|
帕布昔利布杂质
|
|
Pabuximab impurity
|
帕布昔利布杂质
|
|
Afatinib impurity
|
阿法替尼杂质
|
|
Clevidipine butyrate impurity
|
丁酸氯维地平杂质
|
|
Cefdinir impurity
|
头孢地尼杂质
|
|
6-?amino-7-[(tetrahydro-3-furanyl)oxy]-4(3H)-Quinazolinone
|
阿法替尼杂质
|
1405180-57-5
|
Pabuxilibu impurities
|
帕布昔利布杂质
|
|
Clevidipine Butyrate Impurities
|
丁酸氯维地平杂质
|
|
cefdinir
|
头孢地尼杂质
|
|
NA
|
缬沙坦杂质对照品
|
|
Argatroban iMpurity
|
阿加曲班杂质
|
1448417-84-2
|
acarbose iMpurity
|
阿卡波糖杂质
|
|
Avibactam Impurity
|
阿维巴坦钠杂质
|
1797133-98-2
|
IMp. A (EP): 5-Methyl-2-[(2-nitrophenyl)-aMino]thiophene-3-carbonitrile
|
奥氮平杂质A
|
|
OMEPRAZOLE IMPURITY DOMEPRAZOLE SULPHONE EP STANDARD
|
奥美拉唑杂质
|
|
Methyl 4-Methylcinnamate
|
奥扎格雷杂质
|
7560-43-2
|
Budesonide iMpurity
|
布地奈德杂质
|
192057-49-1
|
2-[4-(2-Methylpropyl)phenyl] ethanol
|
布洛芬杂质
|
2143535-25-3
|
2-(4-ForMylphenyl)propionic Acid
|
布洛芬杂质K
|
|
Vinpocetine Impurity
|
长春西汀杂质
|
102341-40-2
|
Lamivudine impurity
|
拉米夫定杂质
|
|
Riociguat IMpurtiy
|
利奥西呱杂质
|
2920299-23-4
|
Rifaximin impurity B
|
利福昔明杂质B
|
1351775-04-6
|
Piperacillin Impurity
|
哌拉西林杂质
|
2170771-47-6
|
Group Doppler impurity
|
群多普利杂质
|
|
Cefixime Impurity
|
头孢克肟杂质
|
33748-00-4
|
1-Benzyl-4-[(5,6-diMethoxy-1H-inden-2-yl)Methyl]piperidine
|
盐酸多奈哌齐杂质
|
|
Ivabradine IMpurity
|
伊伐布雷定杂质
|
1616710-50-9
|
Irinotecan Hydroxyl Acid
|
伊立替康杂质
|
142677-15-4
|
Edaravone Impurity
|
依达拉奉杂质
|
|
Eplerenone EP Impurity A
|
依普利酮杂质
|
209253-67-8
|
Azithromycin system suitability reference
|
阿奇霉素系统适用性对照品
|
|
Lubiprostone IMpurity
|
鲁比前列酮杂质
|
|